Latent hit series hidden in high-throughput screening data.

Thibault Varin1, Marie-Cecile Didiot, Christian N Parker

  • 1Novartis Institutes for BioMedical Research, Forum 1, Novartis Campus, CH-4056 Basel, Switzerland. thibault.varin@novartis.com

Summary

Compound Set Enrichment (CSE) identifies potential drug candidates ("latent hit series") missed by traditional screening methods. This novel approach analyzes activity distributions to find promising compounds, even without initial clear hits.

Related Concept Videos